doi: 10.1038/nmat4822 3. Srivastava RM, Purohit TA, Chan TA. Diverse neoantigens and the development of cancer therapies. Semin Radiat Oncol (2020) 30(2):113 –28. doi: 10.1016/j.semradonc.2019.12.001 4. Ni Q, Zhang F, Liu Y, Wang Z, Yu G, Liang B, et al. A bi-adjuvant nanovaccine that potentiates immunogenicity of neoantigen for combinationimmunotherapy of colorectal cancer. Sci Adv (2020) 6(12):eaaw6071.